NCT06853912 - Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

Alcohol Use Disorder (AUD)PTSD

Interventions

DRUG

Psilocybin 25 mg

Botanical drug product PEX010(25) contains the drug substance, PYEX, which is primarily composed of psilocybin (delivered in a capsule)

DRUG

Maltodextrin (Placebo)

25 mg of Maltodextrin (delivered in a capsule)

Trial Locations (1)

RECRUITING

University of Washington Center for Novel Therapeutics in Addiction Psychiatry, Seattle

All Listed Sponsors

collaborator

Washington State Legislation

UNKNOWN

lead

Nathan Brashares Sackett

OTHER